Vasu Sethuraman

This inventor holds 4 USPTO granted patents and 13 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignees: Bionomics Inc., Cyclerion Therapeutics, Inc., Ironwood Pharmaceuticals, Inc.. Active years: 2017-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vasu Sethuraman. Retrieved from https://idiyas.com/inventor/vasu-sethuraman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 13)

% Patents Active = 100.0

CIPO Patents = 3

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

Cyclerion Therapeutics, Inc.

patents

2 out of 44

Ironwood Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2017-2023

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11572358 - Solid forms of an sGC stimulator (2023-02-07),

2. 10889577 - Solid forms of an sGC stimulator (2021-01-12),

3. 10266529 - Salts, co-crystals, and polymorphs of an anxiolytic compound (2019-04-23),

4. 9745296 - Salts, co-crystals, and polymorphs of an anxiolytic compound (2017-08-29),

Title: Vasu Sethuraman: Innovator in Pharmaceutical Formulations

Introduction

Vasu Sethuraman is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of solid forms of soluble guanylate cyclase (sGC) stimulators. With a total of 4 patents, his work has the potential to impact the treatment of various diseases.

Latest Patents

Sethuraman's latest patents focus on crystalline solid forms of an sGC stimulator, specifically Compound I. The disclosures detail methods for preparing these solid forms and their applications in pharmaceutical formulations. These formulations are designed to treat and prevent diseases that may benefit from sGC stimulation or an increase in nitric oxide (NO) and cyclic guanosine monophosphate (cGMP) concentrations.

Career Highlights

Throughout his career, Vasu Sethuraman has worked with prominent companies in the pharmaceutical industry, including Cyclerion Therapeutics, Inc. and Bionomics Inc. His expertise in the field has allowed him to contribute to innovative solutions that address critical health challenges.

Collaborations

Sethuraman has collaborated with notable professionals in his field, including Ahmad Hashash and Song Xue. These partnerships have further enhanced his research and development efforts.

Conclusion

Vasu Sethuraman's contributions to pharmaceutical innovations, particularly in sGC stimulators, highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.